BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

US FDA approves first CRISPR-based gene therapy Casgevy for sickle cell; Lyfgenia gets nod, too
Both Vertex Pharmaceuticals Inc.’s Casgevy (exagamglogene autotemcel, exa-cel) and Bluebird Bio Inc.’s Lyfgenia (lovotibeglogene autotemcel, lovo-cel) received U.S. FDA...

More in BioWorld

BioWorld MedTech

Biospectal receives CE mark for blood pressure monitoring app
Biospectal SA has received a CE MDR class IIa medical device certification for its optical fingertip blood pressure monitoring app, Optibp. The device records fingertip...

More in BioWorld MedTech

BioWorld Science

Off-target immune response from modified mRNA impacts future development
The Nobel Prize-winning modification that prevents the innate immune system from recognizing injected mRNA as foreign and blocking transcription of the protein it encodes...

More in BioWorld Science

BioWorld Asia

Samsung Bioepis, Intocell partner for ADC drug development
Samsung Bioepis Co. Ltd. will partner with South Korean biotech Intocell Inc. to develop antibody-drug conjugate (ADC) drugs, continuing the Samsung Group and the wider...

More in BioWorld Asia

BioWorld Insider Podcast

Google’s Scott Penberthy joins the podcast for a visionary discussion that scans the horizon for startling changes artificial intelligence will bring to drug development in the relatively near future.